The 16 most recent market catalysts affecting $BAX, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 19, 2026
Corporate Catalyst
Neutral
Impact 65
Baxter International Announces Appointment Of John Rogers As CFO Effective October 1
The appointment of a new CFO at a company like Baxter International is a moderate corporate catalyst. While not typically a major market mover unless the outgoing CFO was embroiled…
Aug 13, 2026
Corporate Catalyst
Bearish
Impact 75
FDA Classifies Baxter's Removal Of Certain Duo-Vent Solution Set Lots As Class I Recall Over Air Bubble Risk; Baxter Says No Serious Injuries Or Deaths Reported
The FDA's Class I recall designation for Baxter's Duo-Vent Solution Sets is a serious regulatory action, indicating a high probability of adverse health consequences. While Baxter …
Aug 4, 2026
Corporate Catalyst
Bearish
Impact 55
Baxter International Says Anita Zielinski To Resign As Interim CFO, Effective September 15, 2026
Baxter International filed an 8-K to announce the resignation of its Interim CFO, Anita Zielinski, effective September 15, 2026. This matters because a change in a company's chief …
Jul 31, 2026
Corporate Catalyst
Bullish
Impact 55
TD Cowen Maintains Hold on Baxter International, Raises Price Target to $29
TD Cowen analyst Joshua Jennings maintained a 'Hold' rating on Baxter International (BAX) but raised the price target from $24 to $29. This indicates that while the analyst sees so…
Jul 31, 2026
Corporate Catalyst
Bullish
Impact 55
Wells Fargo Maintains Equal-Weight on Baxter International, Raises Price Target to $23
Wells Fargo analyst Larry Biegelsen maintained an 'Equal-Weight' rating on Baxter International but raised the price target from $19 to $23. This indicates that while the analyst d…
Jul 31, 2026
Corporate Catalyst
Bullish
Impact 55
Stifel Maintains Hold on Baxter International, Raises Price Target to $28
This 8-K filing discloses that Stifel analyst Rick Wise has maintained a 'Hold' rating on Baxter International (BAX) while simultaneously raising the price target from $24 to $28. …
Jul 31, 2026
Corporate Catalyst
Bullish
Impact 65
Citigroup Upgrades Baxter International to Neutral, Raises Price Target to $28
Citigroup's upgrade of Baxter International from Sell to Neutral, coupled with a significant price target increase from $17 to $28, signals a shift in analyst sentiment. This posit…
Jul 30, 2026
Corporate Catalyst
Bullish
Impact 95
Baxter Jumps After Q2 Beat, Boosted 2026 Guidance Reflects Turnaround Progress
Baxter International's Q2 results significantly surpassed analyst expectations for both earnings and sales, driven by strong performance in Medical Products & Therapies and Healthc…
Jul 30, 2026
Corporate Catalyst
Bullish
Impact 85
Baxter International shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance above estimates.
This headline represents a significant corporate catalyst for Baxter International. The better-than-expected Q2 results and, more importantly, the raised FY26 guidance, signal stro…
Jul 30, 2026
Corporate Catalyst
Bullish
Impact 75
Baxter International Raises FY2026 Adj EPS Guidance from $1.85-$2.05 to $1.95-$2.15 vs $1.91 Est; Raises FY2026 Sales Guidance from $11.244B-$11.356B to $11.581B-$11.694B vs $11.357B Est
Baxter International (BAX) has announced a significant upward revision to its fiscal year 2026 adjusted EPS and sales guidance. The new EPS range of $1.95-$2.15 is notably higher t…
Jul 30, 2026
Corporate Catalyst
Bearish
Impact 92
Baxter Intl Q2 Adj. EPS $0.54 Beats $0.37 Estimate, Sales $2.960B Beat $2.795B Estimate
Baxter International's Q2 earnings per share of $0.54 significantly surpassed the analyst consensus of $0.37, representing a 45.95% beat. Additionally, quarterly sales of $2.960 bi…
Jul 28, 2026
Corporate Catalyst
Bullish
Impact 55
UBS Maintains Neutral on Baxter International, Raises Price Target to $25
UBS analyst Patrick Wood reiterated a 'Neutral' rating on Baxter International (BAX) but raised the price target from $19 to $25. This action suggests that while the analyst sees i…
Jul 28, 2026
Corporate Catalyst
Bullish
Impact 55
Baxter International shares are trading higher after Stifel raised its price target on the stock from $19 to $24.
This headline indicates a positive corporate catalyst for Baxter International. Analyst upgrades, especially from reputable firms like Stifel, often signal improved fundamentals or…
Jul 28, 2026
Corporate Catalyst
Bullish
Impact 55
Stifel Maintains Hold on Baxter International, Raises Price Target to $24
Stifel analyst Rick Wise maintained a 'Hold' rating on Baxter International (BAX) but increased the price target from $19 to $24. This action suggests that while the analyst sees s…
Jul 27, 2026
Corporate Catalyst
Bullish
Impact 65
Baxter International shares are trading higher after TD Cowen maintained a Hold rating on the stock and raised its price target from $20 to $24.
The primary impact of this news is a moderate positive sentiment for Baxter International (BAX). While the 'Hold' rating itself isn't a strong buy signal, the increased price targe…
Jul 27, 2026
Corporate Catalyst
Bullish
Impact 55
TD Cowen Maintains Hold on Baxter International, Raises Price Target to $24
TD Cowen analyst Joshua Jennings maintained a 'Hold' rating on Baxter International (BAX) but raised the price target from $20 to $24. This action suggests that while the analyst s…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.